default image

Urologie

Information and services of the department

  • Number of inpatient cases: 143

Services search (in the department)


Illness Number of cases
Calculus of kidney and ureter - Calculus of kidney (N20.0) 53
Hydrocele and spermatocele - Other hydrocele (N43.2) 17
Calculus of kidney and ureter - Calculus of ureter (N20.1) 9
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) 8
Obstructive and reflux uropathy - Hydronephrosis with ureteral stricture not elsewhere classified (N13.1) 6
Calculus of kidney and ureter - Calculus of kidney with calculus of ureter (N20.2) 6
Varicose veins of other sites - Scrotal varices (I86.1) 5
Hyperplasia of prostate (N40) 5
Hydrocele and spermatocele - Encysted hydrocele (N43.0) 5
Malignant neoplasm of prostate (C61) not specified
Treatment Number
Insertion, exchange or removal of a ureteral stent (8-137.00) 24
Injection or administration of medicines into the urinary bladder (8-132.3) 23
Surgical occlusion of a hydrocele on the testicle (5-611) 22
Surgical incision into a kidney, insertion of a tube to drain urine from the kidney, removal of a stone (calculus) through a surgical incision, dilatation of the renal pelvis or removal of a stone by endoscopy (5-550.30) 21
Computed tomography (CT) of the pelvis without contrast medium (3-206) 20
(8-137.20) 14
Surgical incision into a kidney, insertion of a tube to drain urine from the kidney, removal of a stone (calculus) through a surgical incision, dilatation of the renal pelvis or removal of a stone by endoscopy (5-550.21) 13
Examination of the ureter by endoscopy (1-665) 12
Destruction of stones in the kidney and urinary tract by the external application of shock waves (8-110.2) 12
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) 11

Hospital information and services for all specialist departments

External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
  • Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
    No participation
Number Group
0 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
0 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
0 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Frau Möschl

Patientenfürsprecherin

Phone: 030 -23601-471
Mail: ed.nilreb@aeigyh-grebeneohcs-ftap

Bettina Heiber

Hygiena / QMG / Medizinprodukte

Phone: 030 -23601-0
Mail: ed.grebeneohcs-kinilk@rebieh.anitteb

Michaela Keßler

Medizincontrolling

Phone: 030 -23601-269
Mail: ed.grebeneohcs-kinilk@relssek.aleahcim

Bettina Heiber

Qualitätsmanagement

Phone: 030 -23601-0
Mail: ed.grebeneohcs-kinilk@rebieh.anitteb

PD Dr. med. Annett Gauruder-Burmester

Ärztliche Direktorin

Phone: 030 -23601-0
Mail: ed.grebeneohcs-kinilk@gnudlemna

Dr. med. Peter Werthemann

Ärztlicher Direktor

Phone: 030 -23601-0
Mail: ed.grebeneohcs-kinilk@gnudlemna